Cargando…

Iron(II) Complexes Supported by Sulfonamido Tripodal Ligands: Endogenous versus Exogenous Substrate Oxidation

[Image: see text] High-valent iron species are known to act as powerful oxidants in both natural and synthetic systems. While biological enzymes have evolved to prevent self-oxidation by these highly reactive species, development of organic ligand frameworks that are capable of supporting a high-val...

Descripción completa

Detalles Bibliográficos
Autores principales: Cook, Sarah A., Ziller, Joseph W., Borovik, A. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203402/
https://www.ncbi.nlm.nih.gov/pubmed/25264932
http://dx.doi.org/10.1021/ic501531g
_version_ 1782340397045907456
author Cook, Sarah A.
Ziller, Joseph W.
Borovik, A. S.
author_facet Cook, Sarah A.
Ziller, Joseph W.
Borovik, A. S.
author_sort Cook, Sarah A.
collection PubMed
description [Image: see text] High-valent iron species are known to act as powerful oxidants in both natural and synthetic systems. While biological enzymes have evolved to prevent self-oxidation by these highly reactive species, development of organic ligand frameworks that are capable of supporting a high-valent iron center remains a challenge in synthetic chemistry. We describe here the reactivity of an Fe(II) complex that is supported by a tripodal sulfonamide ligand with both dioxygen and an oxygen-atom transfer reagent, 4-methylmorpholine-N-oxide (NMO). An Fe(III)–hydroxide complex is obtained from reaction with dioxygen, while NMO gives an Fe(III)–alkoxide product resulting from activation of a C–H bond of the ligand. Inclusion of Ca(2+) ions in the reaction with NMO prevented this ligand activation and resulted in isolation of an Fe(III)–hydroxide complex in which the Ca(2+) ion is coordinated to the tripodal sulfonamide ligand and the hydroxo ligand. Modification of the ligand allowed the Fe(III)–hydroxide complex to be isolated from NMO in the absence of Ca(2+) ions, and a C–H bond of an external substrate could be activated during the reaction. This study highlights the importance of robust ligand design in the development of synthetic catalysts that utilize a high-valent iron center.
format Online
Article
Text
id pubmed-4203402
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-42034022015-09-29 Iron(II) Complexes Supported by Sulfonamido Tripodal Ligands: Endogenous versus Exogenous Substrate Oxidation Cook, Sarah A. Ziller, Joseph W. Borovik, A. S. Inorg Chem [Image: see text] High-valent iron species are known to act as powerful oxidants in both natural and synthetic systems. While biological enzymes have evolved to prevent self-oxidation by these highly reactive species, development of organic ligand frameworks that are capable of supporting a high-valent iron center remains a challenge in synthetic chemistry. We describe here the reactivity of an Fe(II) complex that is supported by a tripodal sulfonamide ligand with both dioxygen and an oxygen-atom transfer reagent, 4-methylmorpholine-N-oxide (NMO). An Fe(III)–hydroxide complex is obtained from reaction with dioxygen, while NMO gives an Fe(III)–alkoxide product resulting from activation of a C–H bond of the ligand. Inclusion of Ca(2+) ions in the reaction with NMO prevented this ligand activation and resulted in isolation of an Fe(III)–hydroxide complex in which the Ca(2+) ion is coordinated to the tripodal sulfonamide ligand and the hydroxo ligand. Modification of the ligand allowed the Fe(III)–hydroxide complex to be isolated from NMO in the absence of Ca(2+) ions, and a C–H bond of an external substrate could be activated during the reaction. This study highlights the importance of robust ligand design in the development of synthetic catalysts that utilize a high-valent iron center. American Chemical Society 2014-09-29 2014-10-20 /pmc/articles/PMC4203402/ /pubmed/25264932 http://dx.doi.org/10.1021/ic501531g Text en Copyright © 2014 American Chemical Society Terms of Use (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html)
spellingShingle Cook, Sarah A.
Ziller, Joseph W.
Borovik, A. S.
Iron(II) Complexes Supported by Sulfonamido Tripodal Ligands: Endogenous versus Exogenous Substrate Oxidation
title Iron(II) Complexes Supported by Sulfonamido Tripodal Ligands: Endogenous versus Exogenous Substrate Oxidation
title_full Iron(II) Complexes Supported by Sulfonamido Tripodal Ligands: Endogenous versus Exogenous Substrate Oxidation
title_fullStr Iron(II) Complexes Supported by Sulfonamido Tripodal Ligands: Endogenous versus Exogenous Substrate Oxidation
title_full_unstemmed Iron(II) Complexes Supported by Sulfonamido Tripodal Ligands: Endogenous versus Exogenous Substrate Oxidation
title_short Iron(II) Complexes Supported by Sulfonamido Tripodal Ligands: Endogenous versus Exogenous Substrate Oxidation
title_sort iron(ii) complexes supported by sulfonamido tripodal ligands: endogenous versus exogenous substrate oxidation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203402/
https://www.ncbi.nlm.nih.gov/pubmed/25264932
http://dx.doi.org/10.1021/ic501531g
work_keys_str_mv AT cooksaraha ironiicomplexessupportedbysulfonamidotripodalligandsendogenousversusexogenoussubstrateoxidation
AT zillerjosephw ironiicomplexessupportedbysulfonamidotripodalligandsendogenousversusexogenoussubstrateoxidation
AT borovikas ironiicomplexessupportedbysulfonamidotripodalligandsendogenousversusexogenoussubstrateoxidation